Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer
Breast cancer is the most common type of malignancy and leading cause of cancer death among women worldwide. Despite the current revolutionary advances in the field of cancer immunotherapy, clinical response in breast cancer is frequently below expectations, in part due to various mechanisms of canc...
Na minha lista:
Principais autores: | Alba Navarro-Ocón (Autor), Jose L. Blaya-Cánovas (Autor), Araceli López-Tejada (Autor), Isabel Blancas (Autor), Rosario M. Sánchez-Martín (Autor), María J. Garrido (Autor), Carmen Griñán-Lisón (Autor), Jesús Calahorra (Autor), Francisca E. Cara (Autor), Francisco Ruiz-Cabello (Autor), Juan A. Marchal (Autor), Natalia Aptsiauri (Autor), Sergio Granados-Principal (Autor) |
---|---|
Formato: | Livro |
Publicado em: |
MDPI AG,
2022-02-01T00:00:00Z.
|
Assuntos: | |
Acesso em linha: | Connect to this object online. |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registros relacionados
-
Antioxidants for the Treatment of Breast Cancer: Are We There Yet?
por: Carmen Griñan-Lison, et al.
Publicado em: (2021) -
Nanomedicines for Overcoming Cancer Drug Resistance
por: Tingting Hu, et al.
Publicado em: (2022) -
Polycaprolactone Nanoparticles as Promising Candidates for Nanocarriers in Novel Nanomedicines
por: Sylwia Łukasiewicz, et al.
Publicado em: (2021) -
Nanomedicine in cancer therapy: promises and hurdles of polymeric nanoparticles
por: Carmen Paus, et al.
Publicado em: (2021) -
Thymoquinone-loaded lipid vesicles: a promising nanomedicine for psoriasis
por: Poonam Negi, et al.
Publicado em: (2019)